Yes, we also deserve a break: company vacations from 😊
en
Hyperhidrosis, also known as excessive underarm sweating, does not typically pose a serious threat to a person’s health. It can, however, be embarrassing and distressing. The inconvenience can also have a negative impact on your quality of life.
There is no way to clearly define excessive sweating, but if underarmpits sweating interferes with your daily life and activities, you might have hyperhidrosis. However, lots of people who suffer from the condition are too embarrassed to seek medical help or believe that nothing can be done to improve their symptoms.
Botulinumtoxin A, also referred to most people as Botox ®, treatment helps control the symptoms of severe underarm sweating. It is used when topical medicines have not worked. Botulinumtoxin A temporarily prevents signals from connecting to stimulate the sweat glands. When the sweat glands do not receive signals, the severe sweating stops. But it also works well for excessive facial sweating, like on the upper lip or forehead.
Yes, more than 7.5 million people are affected by excessive sweating. There has been a 39 per cent increase in Google searches for “excessive sweating” in 2022, and the number is rising.
Botulinum toxin injections temporarily stop the excessive production of sweat but only within the treated areas. In other parts of the body, the production of sweat will continue. The treatment does not require anaesthesia, and you can immediately return to your daily life. In most cases, the treatment lasts between 4-12 months.
To find out if this is the right treatment for you or to get more information, make an appointment with Dr. Liv Kraemer online or call us at 0041 44 211 88 11 during our phone hours.
Hyperhidrosis: Evolving therapies for a well-established phenomenon. Eisenach JH, et al. Mayo Clinic Proceedings. 2005; 80:657.
Hyperhidrosis (Excessive sweating). Barbara Woodward Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2011.
Botulinum toxin for focal hyperhidrosis of the face. George SM, Atkinson LR, Farrant PB, Shergill BS; Br J Dermatol. 2013 Aug 5. doi: 10.1111/bjd.12568.
Treatment of primary axillary hyperhidrosis with botulinum toxin type a: our experience in 50 patients from 2007 to 2010. Scamoni S, Valdatta L, Frigo C, Maggiulli F, Cherubino M. ISRN Dermatol. 2012; 2012.
